{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:18Z","timestamp":1792794918825,"version":"4.5.0"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"38","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>AGEs are molecules formed by nonenzymatic glycation of proteins, lipids,\nand nucleic acids, a process accelerated under hyperglycemic conditions such as DM1.\nThese molecules interact with specific receptors, particularly the Receptor for AGEs\n(RAGE), triggering intracellular signaling cascades that promote oxidative stress\nthrough the generation of Reactive Oxygen Species (ROS) and activation of inflammatory\npathways. A critical pathological mechanism involves the formation of neoantigens,\nmodified self-proteins that elicit immune responses. Structural alterations caused by\nAGEs expose new epitopes or modify existing ones, making them targets for autoreactive\nT cells and autoantibodies. This mechanism is implicated in autoimmune skin diseases\nsuch as vitiligo and bullous pemphigoid. Oxidative stress plays a central role in these\ndiseases, exacerbated by AGEs through the generation of ROS and depletion of antioxidants,\nleading to melanocyte destruction in vitiligo and tissue damage in bullous\npemphigoid. In addition, hypoxia enhances ROS production, mitochondria, and other\ncellular systems contributing to oxidative stress. Emerging evidence suggests that hypoxia\ncan be mitigated by oxygen nanobubbles. Targeting AGE formation and oxidative\nstress presents a promising approach for the management of autoimmune skin disorders\nin DM1. Therapeutic strategies targeting AGE formation, oxidative stress, and immune\ndysregulation show promise for managing autoimmune skin disorders in Type 1 Diabetes\nMellitus (T1DM). AGE inhibitors, such as aminoguanidine and pyridoxamine, reduce\nnon-enzymatic protein glycation, limiting AGE accumulation and inflammatory\nsignaling. Antioxidants, including polyphenols, vitamins C and E, N-acetylcysteine, selenium,\nand hydrogen-rich water, help neutralize Reactive Oxygen Species (ROS), restoring\noxidative balance. Combining AGE inhibitors and antioxidants may provide synergistic\nbenefits by reducing oxidative stress and protein immunogenicity. Additionally,\nimmune modulation therapies, such as Treg therapy and cytokine inhibitors, aim to restore\nimmune tolerance and prevent autoimmune activation. Anti-TNF-\u03b1 and IL-6 inhibitors\noffer targeted inflammation suppression, while RAGE antagonists mitigate AGE-induced\nimmune dysregulation. This study aims to explore the role of Advanced Glycation\nEnd products (AGEs) in the pathogenesis of autoimmune skin disorders associated\nwith type 1 Diabetes Mellitus (DM1) and to evaluate potential therapeutic strategies targeting\nAGE formation and oxidative stress.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673374335250410074811","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:52:08Z","timestamp":1745819528000},"page":"8495-8502","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advanced Glycation End Products and Skin Autoimmune Disorders: Pathogenic Insights into Vitiligo, Bullous Pemphigoid, and Type 1 Diabetes Mellitus"],"prefix":"10.2174","volume":"32","author":[{"given":"Geir","family":"Bj\u00f8rklund","sequence":"first","affiliation":[{"name":"Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Gurgas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hangan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"797026","DOI":"10.3389\/fcell.2021.797026","volume":"9","author":"Chang W.L.","year":"2021","unstructured":"Chang W.L.; Lee W.R.; Kuo Y.C.; Huang Y.H.; Vitiligo: An autoimmune skin disease and its immunomodulatory therapeutic intervention. Front Cell Dev Biol  2021,9,797026","journal-title":"Front Cell Dev Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","volume":"10","author":"Genovese G.","year":"2019","unstructured":"Genovese G.; Di Zenzo G.; Cozzani E.; Berti E.; Cugno M.; Marzano A.V.; New insights into the pathogenesis of bullous pemphigoid: 2019 update. Front Immunol  2019,10,1506","journal-title":"Front Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.62610\/RJOR.2024.1.16.28","volume":"16","author":"Chisnoiu T.","year":"2024","unstructured":"Chisnoiu T.; Mihai C.M.; Pantazi A.C.; Balasa A.L.; Mihai L.; Frecus C.E.; Constantin B.M.; Andrusca A.; Lupu A.; Chirila S.; An overview of celiac disease in childhood type 1 diabetes - A single center experience from South East Romania. Rom J Oral Rehabil  2024,16(1),307-317","journal-title":"Rom J Oral Rehabil"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/jpm13030422","volume":"13","author":"Popoviciu M.S.","year":"2023","unstructured":"Popoviciu M.S.; Kaka N.; Sethi Y.; Patel N.; Chopra H.; Cavalu S.; Type 1 diabetes mellitus and autoimmune diseases: A critical Review of the association and the application of personalized medicine. J Pers Med  2023,13(3),422","journal-title":"J Pers Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","volume":"12","author":"Khalid M.","year":"2022","unstructured":"Khalid M.; Petroianu G.; Adem A.; Advanced glycation end products and diabetes mellitus: Mechanisms and perspectives. Biomolecules  2022,12(4),542","journal-title":"Biomolecules"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1002710","DOI":"10.3389\/fmolb.2022.1002710","volume":"9","author":"Mengstie M.A.","year":"2022","unstructured":"Mengstie M.A.; Chekol Abebe E.; Behaile Teklemariam A.; Tilahun Mulu A.; Agidew M.M.; Teshome Azezew M.; Zewde E.A.; Agegnehu Teshome A.; Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Front Mol Biosci  2022,9,1002710","journal-title":"Front Mol Biosci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jid.2023.03.054","volume":"143","author":"Mai S.","year":"2023","unstructured":"Mai S.; Izumi K.; Mai Y.; Natsuga K.; Nishie W.; Ujiie H.; 053 Conformational epitope mapping of autoantibodies against BP180 in dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid. J Invest Dermatol  2023,143(5)(Suppl.),S9","journal-title":"J Invest Dermatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.3390\/molecules27154922","volume":"27","author":"Yue Q.","year":"2022","unstructured":"Yue Q.; Song Y.; Liu Z.; Zhang L.; Yang L.; Li J.; Receptor for advanced glycation end products (RAGE): A pivotal hub in immune diseases. Molecules  2022,27(15),4922","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/13510002.2021.1962094","volume":"26","author":"Xian D.","year":"2021","unstructured":"Xian D.; Guo M.; Xu J.; Yang Y.; Zhao Y.; Zhong J.; Current evidence to support the therapeutic potential of flavonoids in oxidative stress-related dermatoses. Redox Rep  2021,26(1),134-146","journal-title":"Redox Rep"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.14336\/AD.2017.1121","volume":"9","author":"Fournet M.","year":"2018","unstructured":"Fournet M.; Bont\u00e9 F.; Desmouli\u00e8re A.; Glycation damage: A possible hub for major pathophysiological disorders and aging. Aging Dis  2018,9(5),880-900","journal-title":"Aging Dis"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/ijms25053022","volume":"25","author":"Carri\u00f3n-Barber\u00e0 I.","year":"2024","unstructured":"Carri\u00f3n-Barber\u00e0 I.; Triginer L.; T\u00edo L.; P\u00e9rez-Garc\u00eda C.; Ribes A.; Abad V.; Pros A.; Berm\u00fadez-L\u00f3pez M.; Castro-Boqu\u00e9 E.; Lecube A.; Valdivielso J.M.; Group I.P.; Monfort J.; Salman-Monte T.C.; Role of advanced glycation end products as new biomarkers in systemic lupus erythematosus. Int J Mol Sci  2024,25,3022","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12902-024-01558-9","volume":"24","author":"Christidis G.","year":"2024","unstructured":"Christidis G.; K\u00fcppers F.; Karatayli S.C.; Karatayli E.; Weber S.N.; Lammert F.; Krawczyk M.; Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: Correlations with glycemic control, liver phenotypes and metabolic biomarkers. BMC Endocr Disord  2024,24(1),31","journal-title":"BMC Endocr Disord"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3390\/ijerph18147236","volume":"18","author":"Salazar J.","year":"2021","unstructured":"Salazar J.; Navarro C.; Ortega \u00c1.; Nava M.; Morillo D.; Torres W.; Hern\u00e1ndez M.; Cabrera M.; Angarita L.; Ortiz R.; Chac\u00edn M.; D\u2019Marco L.; Berm\u00fadez V.; Advanced glycation end products: New clinical and molecular perspectives. Int J Environ Res Public Health  2021,18(14),7236","journal-title":"Int J Environ Res Public Health"},{"key":"ref=14","first-page":"123","volume":"26","author":"Forbes J.M.","year":"2005","unstructured":"Forbes J.M.; Soldatos G.; Thomas M.C.; Below the radar: Advanced glycation end products that detour \u201caround the side\u201d. Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? Clin Biochem Rev  2005,26(4),123-134","journal-title":"Clin Biochem Rev"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","volume":"97","author":"Marchioro H.Z.","year":"2022","unstructured":"Marchioro H.Z.; Silva de Castro C.C.; Fava V.M.; Sakiyama P.H.; Dellatorre G.; Miot H.A.; Update on the pathogenesis of vitiligo. An Bras Dermatol  2022,97(4),478-490","journal-title":"An Bras Dermatol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"8498472","DOI":"10.1155\/2022\/8498472","volume":"2022","author":"Xuan Y.","year":"2022","unstructured":"Xuan Y.; Yang Y.; Xiang L.; Zhang C.; The role of oxidative stress in the pathogenesis of vitiligo: A culprit for melanocyte death. Oxid Med Cell Longev  2022,2022,8498472","journal-title":"Oxid Med Cell Longev"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cei\/uxab002","volume":"207","author":"Faraj S.","year":"2022","unstructured":"Faraj S.; Kemp E.H.; Gawkrodger D.J.; Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors. Clin Exp Immunol  2022,207(1),27-43","journal-title":"Clin Exp Immunol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-020-00795-6","volume":"12","author":"Zhang Z.","year":"2020","unstructured":"Zhang Z.; Jing J.; Ye Y.; Chen Z.; Jing Y.; Li S.; Hong W.; Ruan H.; Liu Y.; Hu Q.; Wang J.; Li W.; Lin C.; Diao L.; Zhou Y.; Han L.; Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors. Genome Med  2020,12(1),101","journal-title":"Genome Med"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2018.00407","volume":"9","author":"Fang H.","year":"2018","unstructured":"Fang H.; Zhang Y.; Li N.; Wang G.; Liu Z.; The autoimmune skin disease bullous pemphigoid: The role of mast cells in autoantibody-induced tissue injury. Front Immunol  2018,9,407","journal-title":"Front Immunol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","volume":"13","author":"Dong H.","year":"2022","unstructured":"Dong H.; Zhang Y.; Huang Y.; Deng H.; Pathophysiology of RAGE in inflammatory diseases. Front Immunol  2022,13,931473","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jsps.2015.03.013","volume":"24","author":"Asmat U.","year":"2016","unstructured":"Asmat U.; Abad K.; Ismail K.; Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J  2016,24(5),547-553","journal-title":"Saudi Pharm J"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1267091","DOI":"10.3389\/fimmu.2023.1267091","volume":"14","author":"Xiang Y.","year":"2023","unstructured":"Xiang Y.; Zhang M.; Jiang D.; Su Q.; Shi J.; The role of inflammation in autoimmune disease: A therapeutic target. Front Immunol  2023,14,1267091","journal-title":"Front Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41423-020-00626-z","volume":"18","author":"Sogkas G.","year":"2021","unstructured":"Sogkas G.; Atschekzei F.; Adriawan I.R.; Dubrowinskaja N.; Witte T.; Schmidt R.E.; Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell Mol Immunol  2021,18(5),1122-1140","journal-title":"Cell Mol Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","volume":"125","author":"McGarry T.","year":"2018","unstructured":"McGarry T.; Biniecka M.; Veale D.J.; Fearon U.; Hypoxia, oxidative stress and inflammation. Free Radic Biol Med  2018,125,15-24","journal-title":"Free Radic Biol Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"11386","DOI":"10.1021\/acsanm.1c01907","volume":"4","author":"Afshari R.","year":"2021","unstructured":"Afshari R.; Akhavan O.; Hamblin M.R.; Varma R.S.; Review of oxygenation with nanobubbles: Possible treatment for hypoxic COVID-19 patients. ACS Appl Nano Mater  2021,4(11),11386-11412","journal-title":"ACS Appl Nano Mater"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","volume":"20","author":"Kany S.","year":"2019","unstructured":"Kany S.; Vollrath J.T.; Relja B.; Cytokines in inflammatory disease. Int J Mol Sci  2019,20(23),6008","journal-title":"Int J Mol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"Chaudhuri J.","year":"2018","unstructured":"Chaudhuri J.; Bains Y.; Guha S.; Kahn A.; Hall D.; Bose N.; Gugliucci A.; Kapahi P.; The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality. Cell Metab  2018,28(3),337-352","journal-title":"Cell Metab"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"Xie N.","year":"2023","unstructured":"Xie N.; Shen G.; Gao W.; Huang Z.; Huang C.; Fu L.; Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther  2023,8(1),9","journal-title":"Signal Transduct Target Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/pathophysiology28040034","volume":"28","author":"Vojdani A.","year":"2021","unstructured":"Vojdani A.; Vojdani E.; The role of exposomes in the pathophysiology of autoimmune diseases I: Toxic chemicals and food. Pathophysiology  2021,28(4),513-543","journal-title":"Pathophysiology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13619-022-00132-9","volume":"11","author":"Chen D.","year":"2022","unstructured":"Chen D.; Xu Z.; Cui J.; Chen T.; A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte. Cell Regen  2022,11(1),31","journal-title":"Cell Regen"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"16786","DOI":"10.3390\/ijms242316786","volume":"24","author":"de Nicolas-Ruanes B.","year":"2023","unstructured":"de Nicolas-Ruanes B.; Ballester-Martinez A.; Garcia- Mouronte E.; Berna-Rico E.; Azcarraga-Llobet C.; Fernandez-Guarino M.; From molecular insights to clinical perspectives in drug-associated bullous pemphigoid. Int J Mol Sci  2023,24(23),16786","journal-title":"Int J Mol Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.3390\/ijms24032894","volume":"24","author":"Delrue C.","year":"2023","unstructured":"Delrue C.; Speeckaert R.; Delanghe J.R.; Speeckaert M.M.; The potential influence of advanced glycation end products and (s)RAGE in rheumatic diseases. Int J Mol Sci  2023,24(3),2894","journal-title":"Int J Mol Sci"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"837222","DOI":"10.3389\/fmed.2022.837222","volume":"9","author":"Chen C.Y.","year":"2022","unstructured":"Chen C.Y.; Zhang J-Q.; Li L.; Guo M.M.; He Y.F.; Dong Y.M.; Meng H.; Yi F.; Advanced glycation end products in the skin: Molecular mechanisms, methods of measurement, and inhibitory pathways. Front Med  2022,9,837222","journal-title":"Front Med"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.37349\/etat.2023.00170","volume":"4","author":"Palanissami G.","year":"2023","unstructured":"Palanissami G.; Paul S.F.D.; AGEs and RAGE: Metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. Explor Target Antitumor Ther  2023,4(5),812-849","journal-title":"Explor Target Antitumor Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/nu15061436","volume":"15","author":"Kurowska A.","year":"2023","unstructured":"Kurowska A.; Ziemich\u00f3d W.; Herbet M.; Pi\u0105tkowska-Chmiel I.; The role of diet as a modulator of the inflammatory process in the neurological diseases. Nutrients  2023,15(6),1436","journal-title":"Nutrients"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3390\/cells11213503","volume":"11","author":"Du C.","year":"2022","unstructured":"Du C.; Whiddett R.O.; Buckle I.; Chen C.; Forbes J.M.; Fotheringham A.K.; Advanced glycation end products and inflammation in type 1 diabetes development. Cells  2022,11(21),3503","journal-title":"Cells"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","volume":"8","author":"Liu Y.","year":"2017","unstructured":"Liu Y.; Li L.; Xia Y.; BP180 is critical in the autoimmunity of bullous pemphigoid. Front Immunol  2017,8,1752","journal-title":"Front Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"716469","DOI":"10.3389\/fimmu.2021.716469","volume":"12","author":"Barnabei L.","year":"2021","unstructured":"Barnabei L.; Laplantine E.; Mbongo W.; Rieux-Laucat F.; Weil R.; NF-\u03baB: At the borders of autoimmunity and inflammation. Front Immunol  2021,12,716469","journal-title":"Front Immunol"},{"key":"ref=39","first-page":"4391","volume":"14","author":"Kandhwal M.","year":"2022","unstructured":"Kandhwal M.; Behl T.; Singh S.; Sharma N.; Arora S.; Bhatia S.; Al-Harrasi A.; Sachdeva M.; Bungau S.; Role of matrix metalloproteinase in wound healing. Am J Transl Res  2022,14(7),4391-4405","journal-title":"Am J Transl Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e0152376","DOI":"10.1371\/journal.pone.0152376","volume":"11","author":"Serban A.I.","year":"2016","unstructured":"Serban A.I.; Stanca L.; Geicu O.I.; Munteanu M.C.; Dinischiotu A.; RAGE and TGF-\u03b21 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGEs exposed fibroblast cells. PLoS One  2016,11(3),e0152376","journal-title":"PLoS One"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.17305\/bjbms.2017.1961","volume":"17","author":"Tomita T.","year":"2017","unstructured":"Tomita T.; Apoptosis of pancreatic \u03b2-cells in Type 1 diabetes. Bosn J Basic Med Sci  2017,17(3),183-193","journal-title":"Bosn J Basic Med Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1900\/RDS.2004.1.165","volume":"1","author":"Kaneto H.","year":"2004","unstructured":"Kaneto H.; Nakatani Y.; Kawamori D.; Miyatsuka T.; Matsuoka T.A.; Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud  2004,1(4),165-174","journal-title":"Rev Diabet Stud"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.3390\/nu14193982","volume":"14","author":"Zawada A.","year":"2022","unstructured":"Zawada A.; Machowiak A.; Rychter A.M.; Ratajczak A.E.; Szymczak-Tomczak A.; Dobrowolska A.; Krela-Ka\u017amierczak I.; Accumulation of advanced glycation end-products in the body and dietary habits. Nutrients  2022,14(19),3982","journal-title":"Nutrients"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1016\/j.carbon.2012.02.087","volume":"50","author":"Akhavan O.","year":"2012","unstructured":"Akhavan O.; Kalaee M.; Alavi Z.S.; Ghiasi S.M.A.; Esfandiar A.; Increasing the antioxidant activity of green tea polyphenols in the presence of iron for the reduction of graphene oxide. Carbon  2012,50(8),3015-3025","journal-title":"Carbon"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/07315724.2003.10719272","volume":"22","author":"Padayatty S.J.","year":"2003","unstructured":"Padayatty S.J.; Katz A.; Wang Y.; Eck P.; Kwon O.; Lee J.H.; Chen S.; Corpe C.; Dutta A.; Dutta S.K.; Levine M.; Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr  2003,22(1),18-35","journal-title":"J Am Coll Nutr"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2300269","DOI":"10.1002\/mnfr.202300269","volume":"67","author":"Ni C.","year":"2023","unstructured":"Ni C.; Zhou W.; Yu M.; Li X.; Li J.; Cui Y.; Cui W.; Vitamin E.; Vitamin E treatment improves the antioxidant capacity of patients receiving dialysis: A systematic review and meta-analysis. Mol Nutr Food Res  2023,67(22),2300269","journal-title":"Mol Nutr Food Res"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.3390\/jcm13144127","volume":"13","author":"Santus P.","year":"2024","unstructured":"Santus P.; Signorello J.C.; Danzo F.; Lazzaroni G.; Saad M.; Radovanovic D.; Anti-inflammatory and anti-oxidant properties of n-acetylcysteine: A fresh perspective. J Clin Med  2024,13(14),4127","journal-title":"J Clin Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41598-019-42633-9","volume":"9","author":"Amani H.","year":"2019","unstructured":"Amani H.; Habibey R.; Shokri F.; Hajmiresmail S.J.; Akhavan O.; Mashaghi A.; Pazoki-Toroudi H.; Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Sci Rep  2019,9(1),6044","journal-title":"Sci Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1016\/j.ijhydene.2015.02.106","volume":"40","author":"Akhavan O.","year":"2015","unstructured":"Akhavan O.; Azimirad R.; Gholizadeh H.T.; Ghorbani F.; Hydrogen-rich water for green reduction of graphene oxide suspensions. Int J Hydrogen Energy  2015,40(16),5553-5560","journal-title":"Int J Hydrogen Energy"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"13162","DOI":"10.3390\/ijms241713162","volume":"24","author":"Mu\u00f1oz-S\u00e1nchez G.","year":"2023","unstructured":"Mu\u00f1oz-S\u00e1nchez G.; God\u00ednez-M\u00e9ndez L.A.; Fafutis-Morris M.; Delgado-Rizo V.; Effect of antioxidant supplementation on NET formation induced by LPS in vitro; the roles of vitamins E and C, glutathione, and N-acetyl cysteine. Int J Mol Sci  2023,24(17),13162","journal-title":"Int J Mol Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2035117","DOI":"10.1080\/21645515.2022.2035117","volume":"18","author":"Goswami T.K.","year":"2022","unstructured":"Goswami T.K.; Singh M.; Dhawan M.; Mitra S.; Emran T.B.; Rabaan A.A.; Mutair A.A.; Alawi Z.A.; Alhumaid S.; Dhama K.; Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders \u2013 Advances and challenges. Hum Vaccin Immunother  2022,18(1),2035117","journal-title":"Hum Vaccin Immunother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"112724","DOI":"10.1016\/j.intimp.2024.112724","volume":"140","author":"Huang Q.","year":"2024","unstructured":"Huang Q.; Zhu J.; Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence. Int Immunopharmacol  2024,140,112724","journal-title":"Int Immunopharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","volume":"206","author":"Zhou M.","year":"2024","unstructured":"Zhou M.; Zhang Y.; Shi L.; Li L.; Zhang D.; Gong Z.; Wu Q.; Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions \u2013 A review. Pharmacol Res  2024,206,107282","journal-title":"Pharmacol Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1037186","DOI":"10.3389\/fnut.2022.1037186","volume":"9","author":"Kang Q.","year":"2022","unstructured":"Kang Q.; Dai H.; Jiang S.; Yu L.; Advanced glycation end products in diabetic retinopathy and phytochemical therapy. Front Nutr  2022,9,1037186","journal-title":"Front Nutr"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673374335250410074811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/241543\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673374335250410074811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:20:45Z","timestamp":1760674845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/241543\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673374335250410074811","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}